Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 8, 2017
TherapeuticsMD Receives Complete Response Letter from FDA for TX-004HR New Drug Application
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced that it received a Complete Response Letter (CRL) from the ...
May 8, 2017
Eiger Announces Presentation of Prevalence Data of Hepatitis Delta Virus (HDV) Infection in the U.S. at Digestive Disease Week (DDW) in Chicago
PALO ALTO, Calif., May 8, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., (EIGR) today announced HDV/HBV co-infection prevalence data from an International Classification of Diseases (ICD) analysis ...
May 8, 2017
Lipocine Announces Financial and Operational Results for the First Quarter 2017
SALT LAKE CITY, May 08, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced financial results for the first quarter ended ...
May 8, 2017
DelMar Presents New Mechanism of Action Data for its Lead Agent VAL-083 in Temozolomide-Resistant Glioblastoma Multiforme (GBM) at the World Federation of Neuro-Oncology Societies (WFNOS)
VANCOUVER, British Columbia and MENLO PARK, Calif., May 8, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on developing new ...
May 8, 2017
Kamada to Host First Quarter 2017 Financial Results Conference Call on May 16
NESS ZIONA, Israel, May 08, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that ...
May 8, 2017
Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting
ROCKVILLE, Md., May 08, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
May 5, 2017
Erin Andrews to Participate in Cervical Cancer Educational Forum Hosted by Sylvester Comprehensive Cancer Center and Gilda’s Club, Sponsored by Advaxis
HOLLYWOOD, Fla.-- (BUSINESS WIRE) -- Erin Andrews, host of ABC’s Dancing with the Stars, reporter with Fox Sports and cervical cancer survivor, will be a special ...
May 5, 2017
Alcobra Provides Update on Cancellation of Extraordinary Meeting Called by Brosh Group
TEL AVIV, Israel, May 05, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (ADHD), an emerging pharmaceutical company focused on the development of new medications to treat ...
May 5, 2017
Achaogen Receives Investment from the Bill & Melinda Gates Foundation to Develop Antibodies Against Gram-Negative Bacteria
SOUTH SAN FRANCISCO, Calif., May 05, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing novel antibacterials addressing multidrug-resistant (MDR) gram-negative infections, ...
May 5, 2017
First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting
NASHUA, N.H. and VIENNA, Austria, May 05, 2017 (GLOBE NEWSWIRE) -- (Booth #4330) - iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and ...
May 5, 2017
Rockwell Medical Schedules First Quarter 2017 Earnings Call
WIXOM, Mich., May 05, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
May 5, 2017
Rexahn Effects 1-for-10 Reverse Stock Split
ROCKVILLE, Md., May 05, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) (“Rexahn” or the “Company”), a clinical stage biopharmaceutical company developing innovative, targeted ...
May 4, 2017
Gemphire to Host Key Opinion Leader Lunch on the Evolving NASH Landscape
LIVONIA, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
May 4, 2017
Zogenix Provides Corporate Update and Reports First Quarter 2017 Financial Results
EMERYVILLE, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system ...
May 4, 2017
Mirati Therapeutics Reports First Quarter 2017 Financial Results
SAN DIEGO, May 4, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, reported financial results for the first quarter 2017 ...
May 4, 2017
TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week
Leuven (BELGIUM) - May 4, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory ...
May 4, 2017
Addex ADX71441 Preclinical Results for Treatment of Alcohol Use Disorder Published in Journal of Psychopharmacology
Geneva, Switzerland, 4 May 2017 - Addex Therapeutics (ADXN.SW) announced today that the results of a preclinical study evaluating ADX71441 in animal models of alcohol use ...
May 4, 2017
SciClone Pharmaceuticals To Report First Quarter 2017 Financial Results On May 10, 2017
FOSTER CITY, Calif., May 4, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) today announced that it plans to report financial results for the first quarter ...
May 4, 2017
BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017
BOTHELL, Wash., May 4, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storageand cryopreservation freeze media ...
May 4, 2017
Paratek Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results and Provides Clinical Update
BOSTON, May 04, 2017 (GLOBE NEWSWIRE) --  Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
Page 144 of 145